Skip to Main Content

Advertisement

Skip Nav Destination

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

Blood (2019) 133 (9): 893–901.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement